Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women

Free Radical Biology and Medicine

Volumn 45, Issue 4, 2008, Pages 503-511

  Devries, Michaela C ^a   Hamadeh, Mazen J ^a,b   Glover, Alexander W ^a   Raha, Sandeep ^a   Samjoo, Imtiaz A ^a   Tarnopolsky, Mark A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b YORK UNIVERSITY   (Canada)

Author keywords

Antioxidant enzymes; Endurance training; Inflammatory markers; Obesity; Reactive oxygen species

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; ADIPONECTIN; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; INTERLEUKIN 6; LEPTIN; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MUSCLE BIOPSY; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN URINE LEVEL; URINALYSIS; WEIGHT CHANGE; WEIGHT REDUCTION;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; EXERCISE; FEMALE; HUMANS; INFLAMMATION; INSULIN; MUSCLES; OBESITY; OXIDATIVE STRESS; WEIGHT LOSS;

EID: 46649094770     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.04.039     Document Type: Article

References (79)

1. Russell A., Gastaldi G., Bobbioni-Harsch E., Arboit P., Gobelet C., Deriaz O., Golay A., Witztum J., and Giacobino J. Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids?. FEBS Lett. 551 (2003) 104-106
2. Olusi S. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotective enzymes in humans. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 1159-1164
3. Block G., Dietrich M., Norkus E., Morrow J., Hudes M., Caan B., and Packer L. Factors associated with oxidative stress in human populations. Am. J. Epidemiol. 156 (2002) 274-285
4. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., and Shimomura I. Increased oxidative stress in obesity and its impact on the metabolic syndrome. J. Clin. Invest. 114 (2004) 1752-1761
5. Katsuki A., Suematsu M., Gabazza E., Murashima S., Nakatani K., Togashi K., Yano Y., Adachi Y., and Sumida Y. Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res. Clin. Pract. 73 (2006) 310-314
6. Suematsu M., Katsuki A., Sumida Y., Gabazza E., Murashima S., Matsumoto K., Kitagawa N., Akatsuka H., Hori Y., Nakatani K., Togashi K., Yano Y., and Adachi Y. Decreased circulating levels of active grhelin are associated wtih increased oxidative stress in obese subjects. Eur. J. Endocrinol. 153 (2005) 403-407
7. Dandona P., Mohanty P., Ghanim H., Aljada A., Browne R., Hamouda W., Prabhala A., Afzal A., and Garg R. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J. Clin. Endocrinol. Metab. 86 (2001) 355-362
8. Davi G., Guagnano M.T., Ciabattoni G., Basili S., Falco A., Marinopiccoli M., Nutini M., Sensi S., and Patrono C. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288 (2002) 2008-2014
9. Keaney Jr. J.F., Larson M.G., Vasan R.S., Wilson P.W.F., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., and Benjamin E.J. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 434-439
10. Virgolici B., Mohora M., Stoian I., Lixandru D., Gaman L., and Paveliu F. A comparative oxidative stress study: obesity with and without diabetes mellitus. Rom. J. Intern. Med. 43 (2005) 261-268
11. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
12. Bastard J., Maachi M., Lagathu C., Kim M., Caron M., Vidal H., Capeau J., and Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17 (2006) 4-12
13. Forouhi N., Sattar N., and McKeigue P. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int. J. Obes. Relat. Metab. Disord. 25 (2001) 1327-1331
14. Hotamisligil G., Amer P., Caro J., Atkinson R., and Spiegelman B. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
15. Hotamisligil G., Shargill N., and Spiegelman B. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
16. Kern P.R.S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor-alpha and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. 280 (2001)
17. Park H., Park J., and Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract. 69 (2005) 29-35
18. Pradhan A.M.J.E., Rifai N., Buring J., and Ridker P. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
19. Evans J., Goldfine I., Madduz B., and Grodsky G. Are oxidative stress-activated signalling pathways mediators of insulin resistance and beta-cell dysfunction. Diabetes 52 (2003) 1-8
20. Houstis N., Rosen E., and Lander E. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
21. Peeters A., Netea M., Janssen M., Kullberg B., and Van der Meer J.T.T. Pro-inflammatory cytokines in patients with essential hypertension. Eur. J. Clin. Invest. 31 (2001) 31-36
22. Touyz R. Reactive oxygen species, vascular oxidative stress, and redox signalling in hypertension: what is the clinical significance. Hypertension 44 (2004) 248-252
23. Vincent H., and Taylor A. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int. J. Obes. 30 (2006) 400-418
24. Yu B. Cellular defenses against oxidative damage from reactive oxygen species. Physiol. Rev. 74 (1994) 139-162
25. Thorand B., Baumert J., Doring A., Herder C., Kolb H., Rathmann W., Giani G., Koenig W., and Group K. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184 (2006) 216-224
26. Fan J., Frey R.S., Rahman A., and Malik A.B. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-alpha -induced NF-kappa B activation and intercellular adhesion molecule-1 expression in endothelial cells. J. Biol. Chem. 277 (2002) 3404-3411
27. Yamagishi S., Inagaki Y., Nakamura T., Abe R., Shimizu T., Yoshimura A., and Imaizumi T. Pigment epithelium-derived factor inhibits TNF-alpha induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J. Mol. Cell. Cardiol. 37 (2004) 497-506
28. Fan J., Frey R.S., Rahman A., and Malik A.B. Role of Neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-alpha -induced NF-kappa B activation and intercellular adhesion molecule-1 expression in endothelial cells. J. Biol. Chem. 277 (2002) 3404-3411
29. Block G., Dietrich M., Norkus E., Morrow J., Hudes M., Caan B., and Packer L. Factors associated with oxidative stress in human populations. Am. J. Epidemiol. 156 (2002) 274-285
30. Bruce C., Thrush A., Mertz V., Bezaire V., Chabowski A., Heigenhauser G., and Dyck D. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am. J. Physiol. Endocrinol. Metab. 291 (2006) 99-107
31. Christ-Roberts C., Pratipanawatr T., Pratipanawatr W., Berria R., Belfort R., Kashyap S., and Mandarino L. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signalling in overweight nondiabetic and type 2 diabetic subjects. Metabolism 53 (2004) 1233-1242
32. Denton J., Schultz R., Jamurtas A., and Angelopoulos T. Improvements in glucose tolerance in obese males with abnormal glucose tolerance following 10 days of aerobic exercise. Prev. Med. 38 (2004) 885-888
33. Elosua R., Molina L., Fito M., Arquer A., Sanchez-Quesada J.C., Covas M.I., Ordonez-Llanos J., and Marrugat J. Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis 167 (2003) 327-334
34. Powers S., Demirel H., Vincent H., Coombes J., Naito H., Hamilton K., Shanely R., and Jessup J. Exercise training improves myocardial tolerance to in vivo ischemia-reperfusion in the rat. Am. J. Physiol. 275 (1998) R1468-R1477
35. Powers S., Lennon S., Quindry J., and Mehta J. Exercise and cardioprotection. Curr. Opin. Cardiol. 17 (2002) 495-502
36. Pescatello L., Miller B., Danias P., Werner M., Hess M., Baker C., and Jane De Souza M. Dynamic exercise normalizes resting blood pressure in mildly hypertensive premenopausal women. Am. Heart J. 138 (1999) 916-921
37. Durstine J., Grandjean P., Cox C., and Thompson P. Lipids, lipoproteins, and exercise. J. Cardiopulm. Rehabil. 22 (2002) 385-398
38. Westhoff T., Franke N., Schmidt S., Vallbracht-Israng K., Meissner R., Yildirim H., Schlattmann P., Zidek W., Dimeo F., and van der Giet M. Too old to benefit from sports? The cardiovascular effects of exercise training in elderly subjects treated for isolated systolic hypertension. Kidney Blood Press. Res. 30 (2007) 240-247
39. Chang S., Chen Y., Change W., Liu I., and Cheng J. Increase of anti-oxidation by exercise in the liver of obese Zucker rats. Clin. Exp. Pharmacol. Physiol. 31 (2004) 506-511
40. Miyazaki H., Oh-ishi S., Ookawara T., Kizaki T., Toshinai K., Ha S., Haga S., Ji L., and Ohno H. Strenuous endurance training in humans reduces oxidative stress following exhausting exercise. Eur. J. Appl. Physiol. 84 (2001) 1-6
41. Fukai T., Siefried M., Ushio-Fukai M., Cheng Y., Kojda G., and Harrison D. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J. Clin. Invest. 105 (2000) 1631-1639
42. Ficicilar H., Zergeroglu A., Ersoz G., Erdogan A., Ozdemir S., and Tekin D. The effects of short-term training on platelet function and total antioxidant capacity in rats. Physiol. Res. 55 (2006) 151-156
43. Brites F., Zago V., Verona J., Muzzio M., Wikinski R., and Schreier L. HDL capacity to inhibit LDL oxidation in well-trained triathletes. Life Sci. 78 (2006) 3074-3081
44. Dekany M., Nemeskeri V., Gyare I., Harbula J., Malomsoki J., and Pucsok J. Antioxidant status of interval-trained athletes in various sports. Int. J. Sports Med. 27 (2006) 112-116
45. Karolkiewicz J., Szczesniak L., Deskur-Smielecko E., Nowak A., Stemplewski R., and Szeklicki R. Oxidative stress and antioxidant defense system in healthy, elderly men: relationship to physical activity. Aging Male 6 (2003) 100-105
46. Vincent H., Bourguignon C., and Vincent K. Resistance training lowers exercise-induced oxidative stress and homocysteine levels in overweight and obese older adults. Obesity 14 (2006) 1921-1930
47. Dekker M., Lee S., Hudson R., Kilpatrick K., Graham T., Ross R., and Robinson L. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabolism 56 (2007) 332-338
48. Hickey M., Houmard J., Considine R., Tyndall G., Midgette J., Gavigan K., Weidner M., McCammon M., Israel R., and Caro J. Gender-dependent effects of exercise training on serum leptin levels in humans. Am. J. Physiol. 272 (1997) E562-E566
49. Ishii T., Yamakita T., Yamagami K., Yamamoto T., Miyamoto M., Kawasaki K., Hosoi M., Yoshioka K., Sato T., Tanaka S., and Fujii S. Effect of exercise training on serum leptin levels in type 2 diabetic patients. Metabolism 50 (2001) 1136-1140
50. Pasman W., Westerterp-Plantenga M., and Saris W. The effect of exercise training on leptin levels in obese males. Am. J. Physiol. 274 (1998) E280-E286
51. Hulver M., Zheng D., Tanner C., Houmard J., Kraus W., Slentz C., Sinha M., Pories W., MacDonald K., and Dohm G. Adiponectin is not altered with exercise training despite enhanced insulin action. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E861-E865
52. Nassis G., Papantakou K., Skenderi K., Triandafillopoulou M., Kavouras S., Yannakoulia M., Chrousos G., and Sidossis L. Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls. Metab. Clin. Exp. 54 (2005) 1472-1479
53. Perusse L., Collier G., Gagnon J., Leon A., Rao D., Skinner J., Wilmore J., Nadeau A., Zimmet P., and Bouchard C. Acute and chronic effects of exercise on leptin levels in humans. J. Appl. Physiol. 83 (1997) 5-10
54. Yang W., Lee W., Funahashi T., Tanaka S., Matsuzawa Y., Chao C., Chen C., Tai T., and Chuang L. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 86 (2001) 3815-3819
55. Yokoyama H., Emoto M., Araki T., Fujiwara S., Motoyama K., Morioka T., Koyama H., Shoji T., Okuno Y., and Nishizawa. Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes. Diabetes Care 27 (2004) 1756-1758
56. Lowry O., Rosebrough N., Farr A., and Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
57. Parise G., Brose A., and Tarnopolsky M. Resistance exercise training decreases oxidative damage to DNA and increases cytochrome oxidase activity in older adults. Exp. Gerontol. 40 (2005) 173-180
58. Emoto M., Nishizawa Y., Maekawa K., Hiura Y., Kanda H., Kawagishi T., Shoji T., Okuno Y., and Morii H. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22 (1999) 818-822
59. Mahoney D., Kaczor J., Bourgeois J., Yasuda N., and Tarnopolsky M. Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle. Muscle Nerve 33 (2006) 809-816
60. Decsi T., Molnar D., and Koletzko B. Reduced plasma concentrations of alpha-tocopherol and beta-carotene in obese boys. J. Pediatr. 130 (1997) 653-655
61. Strauss R. Comparison of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and non obese children (NHANES III). National Health and Nutrition Examination Survey. J. Pediatr. 134 (1999) 160-165
62. Lopes H., Martin K., Nashar K., Morrow J., Goodfriend T., and Egan B. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 41 (2003) 422-430
63. Salazar D., Sorge C., Jordan S., and Cocoran G. Obesity decreases hepatic gluthathione concentrations and markedly potentiates allyl alcohol-induced periportal necrosis in the overfed rat. Int. J. Obes. 18 (1994) 25-33
64. Gore M., Fiebig R., Hollander J., Leeuwenburgh C., Ohno H., and Ji L. Endurance training alters antioxidant enzyme gene expression in rat skeletal muscle. Can. J. Physiol. Pharmacol. 76 (1998) 1139-1145
65. Alessio H., Hagerman A., Fulkerson B., Ambrose J., Rice R., and Wiley R. Generation of reactive oxygen species after exhaustive aerobic and isometric exercise. Med. Sci. Sports Exerc. 32 (2000) 1576-1581
66. Vincent H., Vincent K., Bourguignon C., and Braith R. Obesity exacerbates oxidative stress levels after acute exercise. Med. Sci. Sports Exerc. 36 (2004) 772-779
67. Sen C., and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10 (1996) 709-720
68. Pou K., Massaro J., Hoffmann U., Vasan R., Maurovich-Horvat P., Larson M., Keaney J.J., Meigs J., Lipinska I., Kathiresan S., Murabito J., O'Donnell C., Benjamin E., and Fox C. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 116 (2007) 1234-1241
69. Fujita K., Nishizawa H., Funahashi T., Shimomura I., and Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ. J. 70 (2006) 1437-1442
70. Stewart K., Bacher A., Turner K., Lim J., Hees P., Shapiro E., Tayback M., and Ouyang P. Exercise and risk factors associated with metabolic syndrome in older adults. Am. J. Prev. Med. 28 (2005) 9-18
71. Kern P., Di Gregorio G., Lu T., Rassouli N., and Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52 (2003) 1779-1785
72. Bluher M., Bullen J.J., Lee J., Kralisch S., Fasshauer M., Kloting N., Niebauer J., Schon M., Williams C., and Mantzoros C. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical therapy. J. Clin. Endocrinol. Metab. 91 (2006) 2310-2316
73. Santos A., Lopes C., Guimaraes J., and Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int. J. Obes. (London) 29 (2005) 1452-1456
74. Minokoshi Y., Kim Y., Peroni O., Fryer L., Muller C., Carling D., and Kahn B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415 (2002) 339-343
75. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B., and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
76. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., and Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
77. de Alvaro C., Teruel T., Hernandez R., and Lorenzo M. Tumor necrosis factor a produces insulin resistance in skeletal muscle by activation of inhibitor kB kinase in a p38 MAPK-dependent manner. J. Biol. Chem. 279 (2004) 17070-17078
78. Bloch-Damti A., and Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid. Redox Signal. 7 (2005) 1553-1567
79. Host H., Hansen P., Nolte L., Chen M., and Holloszy J. Rapid reversal of adaptive increases in muscle GLUT-4 and glucose transport capacity after training cessation. J. Appl. Physiol. 84 (1998) 798-802